Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;69(3):447-456.
doi: 10.1016/j.jadohealth.2021.02.011. Epub 2021 Apr 8.

Trends and Patterns of Tobacco and Nicotine Product Use Among Youth in Canada, England, and the United States From 2017 to 2019

Katherine A East  1 , Jessica L Reid  2 , Vicki L Rynard  2 , David Hammond  2
Affiliations

Trends and Patterns of Tobacco and Nicotine Product Use Among Youth in Canada, England, and the United States From 2017 to 2019

Katherine A East et al. J Adolesc Health. 2021 Sep.

Abstract

Purpose: The tobacco and nicotine market is diversifying. Implications for public health will depend on trends in use, including overall use, and who is using these products. This study examined differences over time (2017-2019), across countries (Canada, England, the United States (US)), and by smoking and vaping, in use of other tobacco/nicotine products and overall use.

Methods: The study includes online repeat cross-sectional surveys of youth aged 16-19 years in Canada (N = 11,714), England (N = 11,170), US (N = 11,838) in 2017, 2018, and 2019. Past 30-day use of tobacco/nicotine products (any, cigarette, e-cigarette, other combusted [cigars/cigarillos/waterpipe], other non-combusted [smokeless tobacco/nicotine replacement therapies) were examined by country, year, and, for other combusted and non-combusted products, past 30-day cigarette smoking and vaping. Use of emerging products (IQOS, nicotine pouches) was explored in 2018-2019.

Results: From 2017 to 2019, use of any product increased in Canada (17.1%-23.2%, AOR = 1.07 [95% CI = 1.04-1.09]) and the US (18.0%-24.0%, AOR = 1.06 [1.04-1.09]) but not England (20.8%-21.7%, AOR = 1.01 [.99-1.03]). Use of other combusted products (cigars/cigarillos/waterpipe) showed little change (Canada: 8.1%-7.8%; England: 6.3%-7.3%; US: 8.6%-8.5%; p ≥ .151). Use of other non-combusted products (smokeless/nicotine replacement therapies) increased in all countries (Canada: 1.5%-3.2%, AOR = 1.02 [1.01-1.02]; England: 1.4%-2.6%, AOR = 1.02 [1.01-1.03]; US: 3.3%-4.9%, AOR = 1.02 [1.01-1.02]). Vaping increased in all countries (Canada: 8.4%-17.8%; England: 8.7%-12.6%; United States: 11.1%-18.5%; all p < .001). Smokers and vapers reported greater use of other combusted and non-combusted products than those who neither smoked/vaped (p < .001). Emerging product use was rare (≤1.5%).

Conclusions: Youth past 30-day tobacco and nicotine product use increased from 2017 to 2019 in Canada and the United States, largely due to increases in vaping and other non-combusted products. "Other" tobacco/nicotine products were used predominantly by youth who smoked cigarettes and/or vaped.

Keywords: Adolescent; Electronic nicotine delivery systems; Nicotine; Prevalence; Smoking; Surveys and questionnaires; Tobacco products.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests. DH has served as a paid expert witness in legal challenges against tobacco companies. KAE, JLR & VLR have no potential conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.. Prevalence of past 30-day use of tobacco and nicotine products in Canada, England, and the US in 2017, 2018, and 2019. Data are weighted.
Sample sizes vary for each product due to pair wise deletion of ‘Don’t know’ and ‘Refused’ responses (see Appendix Table A1). *Included herbal or tobacco, †Without tobacco. NRT=Nicotine Replacement Therapy. Past-30-day use of nicotine pouches was not assessed in 2017 or 2018. Past-30-day use of IQOS was not assessed at 2017.
Figure 2.
Figure 2.. Prevalence of past 30-day use of other combusted and other non-combusted tobacco and nicotine products in Canada, England, and the US by past 30-day cigarette smoking, past 30-day vaping, and past 30-day cigarette smoking/vaping. N=32,525.
% are derived from weighted data. N are derived from unweighted data. Other combusted: At least one of: cigars, little cigars/cigarillos, bidis, waterpipe. Other non-combusted: At least one of: smokeless tobacco, nicotine replacement therapy (NRT). Analyses for combined past 30-day cigarette smoking/vaping (final panel) were not pre-registered and are hence exploratory.
See this image and copyright information in PMC

References

    1. Cummings KM, Ballin S, Sweanor D. The past is not the future in tobacco control. Preventive Medicine. 2020:106183. doi: 10.1016/j.ypmed.2020.106183. - DOI - PMC - PubMed
    1. Benowitz NL. Emerging nicotine delivery products. Implications for public health. Ann Am Thorac Soc. 2014;11(2):231–235. doi: 10.1513/AnnalsATS.201312-433PS. - DOI - PubMed
    1. McNeill A, Munafo MR. Reducing harm from tobacco use. J Psychopharmacol. 2013;27(1):13–18. doi: 10.1177/0269881112458731. - DOI - PubMed
    1. Levy DT, Mumford EA, Cummings KM, Gilpin EA, Giovino G, Hyland A, Sweanor D, Warner KE. The Relative Risks of a Low-Nitrosamine Smokeless Tobacco Product Compared with Smoking Cigarettes: Estimates of a Panel of Experts. Cancer Epidemiol Biomarkers Prev. 2004. doi. - PubMed
    1. McNeill A, Brose LS, Calder R, Bauld L, Robson D. Vaping in England: an evidence update including mental health and pregnancy, March 2020: A report commissioned by Public Health England. 2020. https://www.gov.uk/government/publications/vaping-in-england-evidence-up....

Publication types